Nuvectis Pharma, Inc. (NVCT)
NASDAQ: NVCT · Real-Time Price · USD
7.54
+0.02 (0.27%)
At close: Jul 3, 2025, 1:00 PM
7.91
+0.37 (4.91%)
After-hours: Jul 3, 2025, 4:34 PM EDT

Nuvectis Pharma Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
178105145110--
Market Cap Growth
56.85%-27.66%31.58%---
Enterprise Value
1488712286--
Last Close Price
7.545.418.347.50--
PB Ratio
8.5010.7611.847.72--
P/TBV Ratio
8.5010.7611.847.72--
Quick Ratio
3.252.082.743.232.37-
Current Ratio
3.282.092.753.302.41-
Return on Equity (ROE)
-115.28%-173.41%-168.51%-206.81%-609.74%-
Return on Assets (ROA)
-52.69%-65.64%-69.14%-83.30%--
Return on Capital (ROIC)
-75.12%-113.21%-103.60%-122.13%-171.30%-
Earnings Yield
-11.31%-18.18%-15.40%-17.38%--
Buyback Yield / Dilution
-12.13%-10.01%-22.90%-196.55%-9.44%-
Updated Feb 25, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q